Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

February 24, 2022

Study Completion Date

August 1, 2022

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

FIASP + closed loop device

Participants will be advised to change their usual insulin to the corresponding study visit insulin formulation, 24 hours prior to admission. (For example; if the participant is on insulin aspart, this will be changed to faster-acting aspart 24-hour prior to the admission for closed loop with faster-acting aspart and vice versa).

DEVICE

Insulin aspart (standard of care insulin) + closed loop device

Participants will be advised to maintain their usual insulin 24 hours prior to admission.

Trial Locations (1)

M13 WL

Manchester University Hospitals NHS Foundation Trust, Manchester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Manchester University NHS Foundation Trust

OTHER_GOV